跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 870 条关于
“Nini Wu”
全部
870
临床试验
578
药物
54
机构
12
资讯
226
去年
AI in Oncology: Transforming Community Practice from Patient Care to Revenue Cycles
去年
Community Oncology Practices Expand Access to CAR-T and Bispecific Therapies as Workforce Challenges Persist
11个月前
Wu Yifang Appointed Chairman of Everest Medicines as Company Advances mRNA Cancer Vaccine Platform
2年前
WU-CART-007 Shows Promise in Relapsed/Refractory T-ALL/LBL
去年
WU-CART-007 Demonstrates High Response Rates in Relapsed/Refractory T-ALL/LBL
去年
China CDE Grants Breakthrough Therapy Designation to Sunvozertinib for First-Line EGFR Exon20ins NSCLC
去年
Wugen Secures $115 Million to Advance First-in-Class Off-the-Shelf CAR-T Therapy for T-Cell Malignancies
去年
Sunvozertinib NDA Submitted to FDA for EGFR Exon 20+ NSCLC
5年前
FDA Grants Priority Review to Dizal's Sunvozertinib for EGFR Exon20 Insertion-Positive NSCLC
9个月前
Stanford Study Identifies Biological Mechanism Behind mRNA COVID-19 Vaccine-Associated Myocarditis
第 1 页,共 23 页
上一页
下一页